Skip to content

Interface IFBG100

by Bioventus LLC

Interface IFBG100 is a synthetic bone graft (FDA Class II; FDA product code MQV, Filler, Bone Void, Calcium Compound) made by Bioventus LLC, cleared under FDA 510(k) K132071 on 10 Jan 2014 (1 earlier submission) and listed in FDA GUDID since 6 May 2019 (UDI-DI 00816986020037), active as of 22 Oct 2026. One FDA recall is linked to it.

Active United States. Also listed in GUDID (US).

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None ongoing

1 closed

Documents

Trust

Unverified

Source GUDID, synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number00816986020037 UDI-DI Date6 May 2019ListedStatusListed GUDID: in commercial distribution
United StatesFDA 510(k)SESE from GUDID Substantially Equivalent · Traditional NumberK132071 Date10 Jan 2014DecidedStatusActive

Official records

From the FDA record

Device description
INTERFACE is a synthetic bioactive bone graft for use in the repair of osseous defects. It is supplied as irregular synthetic granules of bioactive glass (45S5 Bioglass), sized from 200 microns to 420 microns. When implanted in living tissue, the material undergoes a time dependent surface modification. The surface reaction results in the formation of a calcium phosphate layer, which is equivalent in composition and structure to the hydroxyapatite found in bone mineral. The biological apatite layer of the granules provides an osteoconductive scaffold for the generation of new osseous tissue. New bone infiltrates around the granules allowing the repair of the defect as the granules are absorbed.
MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied sterile

From the GUDID record (AccessGUDID), as read on 22 Oct 2026, as the labeller entered it.

Across registries

2 registries list this device

  • FDA 510(k) K132071 decided 10 Jan 2014 Active· +1 more in the status table
  • FDA GUDID UDI-DI 00816986020037 listed 6 May 2019 Listed

Recalls

1 recall · FDA

    • Terminated Z-1148-2019 FDA Class II initiated 13 Feb 2019

    The firm became aware of the potential for the products' sterile pouch to be punctured during transit. The packaging failure may introduce a non-sterile device that may lead to patient infection.

Timeline

4 dated events

  1. Cleared FDA 510(k) K112857
  2. Cleared FDA 510(k) K132071
  3. Recall initiated FDA recalls Z-1148-2019
  4. Listed FDA GUDID 00816986020037

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

GUDID

Trade name
Interface
Generic name
Synthetic bone graft
Model / Ref / Catalog
IFBG100
Primary DI / UDI-DI
00816986020037
510(k) Number
FDA product code
MQV
GMDN term
Synthetic bone graft
Device class
Class II
Regulation number
888.3045
GUDID distribution status
In Commercial Distribution
Size
Weight — 1 Gram

Similar devices in this category

Other devices filed under Synthetic bone graft.

Other devices from Bioventus LLC

See all devices from Bioventus LLC →

Properties

  • Supplied sterile
  • Single use
  • Implantable
  • Prescription use
  • Lot / batch number
  • Expiration date
Other properties (9, all answered No)